LifeMD Inc (LFMD)
5.69
+0.27
(+4.98%)
USD |
NASDAQ |
Nov 21, 16:00
5.80
+0.11
(+1.93%)
After-Hours: 20:00
LifeMD Debt to Equity Ratio: -2.361 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | -2.361 |
June 30, 2024 | -4.313 |
March 31, 2024 | -21.46 |
December 31, 2023 | 5.208 |
September 30, 2023 | -1.520 |
June 30, 2023 | -1.299 |
March 31, 2023 | -2.08 |
December 31, 2022 | -0.4096 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.0036 |
December 31, 2021 | 0.0024 |
September 30, 2021 | -0.8025 |
June 30, 2021 | -3.076 |
March 31, 2021 | 0.182 |
December 31, 2020 | 0.5755 |
September 30, 2020 | -0.2405 |
June 30, 2020 | -0.2428 |
March 31, 2020 | -0.1769 |
December 31, 2019 | -0.8245 |
September 30, 2019 | -1.538 |
June 30, 2019 | -0.1785 |
March 31, 2019 | 1.060 |
December 31, 2018 | 0.2756 |
Date | Value |
---|---|
September 30, 2018 | 0.00 |
June 30, 2018 | 0.0479 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.1899 |
September 30, 2017 | 0.0946 |
June 30, 2017 | -0.4957 |
March 31, 2017 | -0.0236 |
December 31, 2016 | -0.581 |
September 30, 2016 | 0.7138 |
June 30, 2016 | 0.3594 |
March 31, 2016 | 1.300 |
December 31, 2015 | 0.9992 |
September 30, 2015 | -0.7781 |
June 30, 2015 | -0.5945 |
March 31, 2015 | -0.6769 |
December 31, 2014 | -0.195 |
September 30, 2014 | -2.213 |
June 30, 2014 | 1.595 |
March 31, 2014 | 0.3416 |
December 31, 2013 | 0.2056 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-21.46
Minimum
Mar 2024
5.208
Maximum
Dec 2023
-1.642
Average
-0.3262
Median
Debt to Equity Ratio Benchmarks
Veradigm Inc | -- |
TruBridge Inc | 1.021 |
Streamline Health Solutions Inc | 0.784 |
LENZ Therapeutics Inc | -- |
Oruka Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 72.56M |
Total Liabilities (Quarterly) | 78.52M |
Shareholders Equity (Quarterly) | -7.720M |
Current Ratio | 0.8254 |
Net Debt Paydown Yield | -0.36% |